Climate Change and Mental Health: Implications for the Psychiatric Workforce.

Climate Change Humans Mental Health Mental Health Services Psychiatry / education Workforce
Environment Planetary health Prevention Psychiatry Public health Workforce

Journal

Psychiatric services (Washington, D.C.)
ISSN: 1557-9700
Titre abrégé: Psychiatr Serv
Pays: United States
ID NLM: 9502838

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 10 8 2021
medline: 4 5 2022
entrez: 9 8 2021
Statut: ppublish

Résumé

Climate change is a major global public mental health crisis that is expected to increase the need for mental health services. Psychiatrists and other mental health care providers must address workforce needs through recruitment, training and education, prevention and intervention, public policy and advocacy, and direct efforts to reduce climate change. This column discusses concrete steps for the psychiatric workforce to take to prepare for growing mental health needs associated with climate change.

Identifiants

DOI: 10.1176/appi.ps.202100227 PMID: 34369808
pubmed: 34369808
doi: 10.1176/appi.ps.202100227
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

592-595

Auteurs

Alison R Hwong (AR)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Emily A Kuhl (EA)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Wilson M Compton (WM)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Tami Benton (T)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Adrienne Grzenda (A)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Benjamin Doty (B)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Laura Thompson (L)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Nitin Gogtay (N)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Diana Clarke (D)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Jonathan Alpert (J)

Department of Psychiatry and Behavioral Sciences, Philip R. Lee Institute for Health Policy Studies, and National Clinician Scholars Program, University of California, San Francisco (Hwong).
San Francisco Veterans Affairs Medical Center, San Francisco (Hwong).
Right Brain/Left Brain, Stafford, Virginia (Kuhl).
National Institute on Drug Abuse, Washington, D.C. (Compton).
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia (Benton).
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Grzenda).
Division of Research, American Psychiatric Association, Washington, D.C. (Doty, Thompson, Gogtay, Clarke).
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Clarke).
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York City (Alpert). Ruth S. Shim, M.D., M.P.H., and Michael T. Compton, M.D., M.P.H., are editors of this column.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes biologiques › Phénomènes écologiques et environnementaux › Processus climatiques › Changement climatique › Climate Change and Mental Health: Implications...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Climate Change and Mental Health: Implications...
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé mentale › Climate Change and Mental Health: Implications...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services de santé mentale › Climate Change and Mental Health: Implications...
questionsmedicales.fr › Professions de santé › Médecine › Psychiatrie › Climate Change and Mental Health: Implications...
questionsmedicales.fr › Administration des services de santé › Organisation et administration › Effectif › Climate Change and Mental Health: Implications...